Women's Cancer News
Sep. 2, 2015

Obama calls for a greater effort to fight ovarian cancer
The Huffington Post
President Barack Obama honored women diagnosed with ovarian cancer and their families and urged more research into prevention, detection and treatment of the disease in a White House proclamation commemorating September as National Ovarian Cancer Awareness Month.

“This month, we stand with all those who continue to fight this devastating disease and with those who have lost loved ones because of it. Along with the advocates, medical researchers, and health care providers who tirelessly battle this disease every day, we rededicate ourselves to the urgent work of increasing awareness and improving care for those with ovarian cancer — and we continue forging a future free from cancer in all its forms,” the proclamation reads.
Click here to read more.

(Tweet your support for ovarian cancer research! #ovariancancer #gyncsm @SGO2015)More

September is Gynecologic Cancer Awareness Month

During the month of September, SGO salutes all members of a woman’s gynecologic cancer team. Thank you for your efforts in research and clinical trials, diligence in educating others within our subspecialty, advocacy work with our elected officials, and commitment to your patients on a daily basis.More

Younger age predicts worse survival from low-grade serous carcinoma of ovary, peritoneum
Healio
Women aged 35 or younger with low-grade serous carcinoma of the ovary or the peritoneum, as well as those with persistent disease upon therapy completion, have worse survival outcomes than older women with the same cancers, according to observational study results published in the Journal of Clinical Oncology. Further, patients with low-grade serous carcinoma of the peritoneum (LGSPC) appear to have a better prognosis than patients with low-grade serous carcinoma of the ovary (LGSOC).More

Beta-blockers linked with extended ovarian cancer survival
Cancer Network
Beta-blockers were associated with increased overall survival in women with epithelial ovarian cancer, according to the results of a recently published retrospective study in the journal Cancer. In the analysis, women who received any beta-blocker had a more than 5-month increase in median overall survival compared with women not receiving beta-blockers.More

New blood test could predict breast cancer relapse risk
CBS News
Weeks or even months before there is evidence of a tumor in scans or biopsies, a simple blood test could detect the risk of relapse in survivors of early stage breast cancer. The "liquid biopsy" developed at the Institute of Cancer Research in London is a kind of blood test that shows promise in detecting cancer DNA in the blood before the cells grow into tumors. The results of a prospective pilot study of the test were published in the journal Science Translational Medicine.More

Risk protocol identifies patients with cancer not allergic to carboplatin, oxaliplatin
Healio
Patients with cancer who had a history of presumed carboplatin- and oxaliplatin-induced hypersensitivity reaction did not appear allergic to the chemotherapy drugs after skin prick tests, according to retrospective study results published in Annals of Allergy, Asthma & Immunology. The risk-stratification protocol appeared to safely identify patients without allergic reaction to the drugs, allowing them to return to an outpatient setting for further treatment without desensitization.More

Genetic test impacts chemo choices in surprising ways
TIME
A study investigates for the first time how a gene-based test is affecting women’s decisions to get chemotherapy. In the new era of personalized medicine, having more information on hand is considered the ideal situation for making more customized, and ideally, effective decisions about medical care. And in a new study, published in JAMA Oncology, of breast cancer patients, researchers show that a relatively new genetic test for evaluating tumors is doing just that. It’s just that the test isn’t necessarily leading to the decisions that experts expected.More

Ureteric injury risk with hysterectomy increased
HealthDay News via Renal & Urology News
In 2001 to 2010, 0.5 percent of women experienced ureteric injury in the year after a hysterectomy, with lower rates for benign versus malignant conditions and rates of injury increasing between 2001 and 2010, according to a study published online in BJOG: An International Journal of Obstetrics and Gynaecology. Amit Kiran, Ph.D., from the London School of Hygiene & Tropical Medicine, and colleagues examined the rates of ureteric injury among women undergoing hysterectomy in a retrospective cohort study. The main outcome measure was ureteric injury within 1 year of hysterectomy.More

Effectiveness of cancer survivorship care plans questioned
Medscape (free login required)
Survivorship care plans (SCPs), recommended for cancer survivors by the Institute of Medicine since 2006, are meant to improve patients' quality of care as they move beyond cancer treatment and deal with its aftermath. But do they work? In a study published online Aug. 24 in the Journal of Clinical Oncology, Dutch researchers found "no evidence of a benefit of SCPs on satisfaction with information provision and care."More